• LAST PRICE
    0.0300
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    0.0800/ 6
  • Open / Previous Close
    --- / 0.0300
  • Day Range
    ---
  • 52 Week Range
    Low 0.0300
    High 0.0300
  • Volume
    ---

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
Table Data Not Available
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
CanadaHAVN
HAVN Life Sciences Inc
859.4K
0.0x
---
CanadaENBI
Entheon Biomedical Corp
1.2M
-2.9x
---
CanadaWAVE
Waverley Pharma Inc
810.0K
-0.4x
---
CanadaOMND
Optimind Pharma Corp
548.9K
-0.5x
---
CanadaMESC
Lophos Holdings Inc
858.6K
-0.7x
---
CanadaTEQ
Terranueva Corp
949.9K
-1.6x
---
As of 2024-11-22

Company Information

HAVN Life Sciences Inc. is a Canada-based biotechnology company. The Company is engaged in the scientific research and development of psychopharmacological and natural health care products. It is focused on standardizing extraction of psychoactive compounds, the development of natural health products, and developing mental health treatments to support brain health and enhance the capabilities of the mind. The Company has two business divisions: HAVN Labs and HAVN Retail. The HAVN Labs division is engaged in the development of research protocols to cover the production of Psilocybe spp. Through its research division, HAVN Labs, it has developed an end-to-end supply chain of GMP naturally derived psychedelic compounds for research. The HAVN Retail division formulates and sells natural health products (NHPs) using compounds. It offers a full range of mushroom and plant extracts that help boost immune function, reduce inflammation and support a healthy lifestyle.

Contact Information

Headquarters
605 - 130 Brew StreetPORT MOODY, BC, Canada V3H 0E3
Phone
604-370-9520
Fax
---

Executives

Chairman of the Board
Victor Neufeld
Director and Chief Executive Officer
Tim Moore
Vice Chairman of the Board, Independent Director
Ricky Brar
Chief Financial Officer
Gordon Clissold
Chief Operating Officer
Jenna Pozar

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$859.4K
Revenue (TTM)
$587.0K
Shares Outstanding
28.6M
HAVN Life Sciences Inc does not pay a dividend.
Beta
---
EPS
$-3.06
Book Value
$0.62
P/E Ratio
0.0x
Price/Sales (TTM)
1.5
Price/Cash Flow (TTM)
---
Operating Margin
-2,619.63%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.